Abstract
Helicobacter pylori (H. pylori) is well-known to be involved in gastric carcinogenesis, associated with deregulation of cell proliferation and epigenetic changes in cancer-related genes. H. pylori infection is largely acquired during childhood, persisting long-term in about half of infected individuals, a subset of whom will go on to develop peptic ulcer disease and eventually gastric cancer, however, the sequence of events leading to disease is not completely understood. Knowledge on carcinogenesis and gastric damage-related biomarkers is abundant in adult populations, but scarce in children. We performed an extensive literature review focusing on gastric cancer related biomarkers identified in adult populations, which have been detected in children infected with H. pylori. Biomarkers were related to expression levels (RNA or protein) and/or methylation levels (DNA) in gastric tissue or blood of infected children as compared to non-infected controls. In this review, we identified 37 biomarkers of which 24 are over expressed, three are under expressed, and ten genes are significantly hypermethylated in H. pylori-infected children compared to healthy controls in at least 1 study. Only four of these biomarkers (pepsinogen I, pepsinogen II, gastrin, and SLC5A8) have been studied in asymptomatically infected children. Importantly, 13 of these biomarkers (β-catenin, C-MYC, GATA-4, DAPK1, CXCL13, DC-SIGN, TIMP3, EGFR, GRIN2B, PIM2, SLC5A8, CDH1, and VCAM-1.) are consistently deregulated in infected children and in adults with gastric cancer. Future studies should be designed to determine the clinical significance of these changes in infection-associated biomarkers in children and their persistence over time. The effect of eradication therapy over these biomarkers in children if proven significant, could lead to modifications in treatment guidelines for younger populations, and eventually promote the development of preventive strategies, such as vaccination, in the near future.
Introduction
Helicobacter pylori (H. pylori) prevalence rates in adult populations vary from 35 to 90%, depending on the detection method used (serology, urea breath test, stool antigen detection test or invasive methods) and socioeconomic development status of the evaluated population (Hooi et al., 2017). H. pylori is epidemiologically relevant due to its causative role in peptic ulcer disease, gastric lymphoma and adenocarcinoma in adults. Annually, nearly one million new cases of gastric cancer (GC) and 738,000 cancer-associated deaths occur worldwide (Karimi et al., 2014) and H. pylori is estimated to cause 89% of all GC cases (Plummer et al., 2016). H. pylori associated carcinogenesis occurs by both indirect and direct mechanisms. The former are mediated by chronic inflammation, leading to increased cell turnover resulting in an accumulation of mitotic errors and by regulatory T cell induction leading to immune response evasion (Bagheri et al., 2016; Kalisperati et al., 2017). Direct mechanisms are mediated by bacterial factors which affect specific molecular targets on the gastric epithelial cells, resulting in DNA damage (Bagheri et al., 2016). Virulence factors, such as CagA (cytotoxin-associated gene A) and VacA (vacuolating cytotoxin A), can induce mutations in genes that regulate the cell-cycle, deficiencies in DNA repair mechanisms, loss of cell adhesion and epigenetic changes, resulting in deregulation of the cell cycle, proliferation, and malignant transformation (Ahn and Lee, 2015). Epigenetic modifications associated with H. pylori include DNA methylation and histone modifications, which may be associated with gastric carcinogenesis (Hanada and Graham, 2014; Shimazu et al., 2015; Valenzuela et al., 2015). Comprehensive reviews on H. pylori associated carcinogenesis or gastric damage-related biomarkers in adults have been widely published (Skierucha et al., 2016; Chmiela et al., 2017).
Helicobacter pylori infection is mostly acquired during childhood, and prevalence estimates range from 20% to 50% in asymptomatic children ≤5 years of age and 38 to 79% in children >5 years of age, with the probability of persistence varying widely from 49 to 95% (Zabala Torrres et al., 2017). The sequence of events that leads from childhood persistent infection to the development of malignant disease in adulthood is partially understood. A long term process occurs in gastric tissue from premalignant lesions (gastritis, atrophy, intestinal metaplasia and dysplasia) to malignant carcinoma, described as the “Correa cascade,” where atrophic gastritis is the first recognizable step in the development of future cancer; non-atrophic gastritis in contrast may lead to benign lesions (Correa and Piazuelo, 2012). Thus, it is important to elucidate molecular mechanisms by which persistent infection in a subgroup of H. pylori infected children may lead to precancerous and cancer lesions in future adulthood.
As this review will synthesize, most studies on clinical outcomes of H. pylori infection or the characterization of genes and molecules in gastric tissue related to infection have been conducted in symptomatic children undergoing endoscopy. Symptoms leading to endoscopic examination were not specified in all the studies reviewed. Clinical guidelines such as the Rome criteria are routinely used worldwide for endoscopy indication. Alarm criteria include a family history of peptic ulcer disease, persistent right upper or right lower quadrant pain, dysphagia, odynophagia, persistent vomiting, gastrointestinal blood loss, nocturnal diarrhea, involuntary weight loss, and deceleration of linear growth, all of which may be manifestations of mucosal inflammation (Hyams et al., 2016). Meanwhile, few studies have evaluated clinical outcomes and molecular markers of gastric damage in asymptomatically infected individuals. Studies in both symptomatic and asymptomatic children are required to better understand the pathogen-host interaction, which may or may not be relevant for disease development. Importantly, biomolecular and gene expression dysregulation found in persistently infected children might be playing a role in disease progression and, in some cases, determining an oncogenic process. To our knowledge, comprehensive reviews on H. pylori associated gastric damage- or oncogenic-related biomarkers in children are scarce, and only a few have focused on biomarkers and genes dysregulation in infected children. These reviews have focused on inflammatory responses (Ernst and Gold, 1999; Razavi et al., 2015) describing both proinflammatory (Th1, Th17) and regulatory responses (Treg), however other molecules related to tissue damage and/or cancer have not been summarized. Here we discuss the biological function and potential role in carcinogenesis/gastric damage of genes and/or proteins, previously identified in adult carcinogenesis, that are differentially expressed and/or methylated among infected versus non-infected children, according to the published literature. For the purpose of this review, we are using the National Institutes of Health Biomarkers Definitions Working Group’s definition of “biomarker”: “a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes or responses to an exposure or intervention” (FDA-NIH Biomarker Working Group, 2019). Thus, we considered biomarkers to be methylated genes and expression products (proteins, mRNA or miRNA) from coding genes, where expression level or methylation status was associated with H. pylori infection in children and with gastric cancer or gastric damage in adults. Our aim is to determine if there is sufficient evidence associating H. pylori infection in symptomatic and asymptomatic children with biomarkers of gastric damage and oncogenesis described in adults.
Definition of Terms
Population of interest was defined as children (0–18 years old), symptomatic or asymptomatic with H. pylori infection determined by any of the following methods: Urea breath test (UBT), stool antigen test, serology, histopathology, culture from gastric biopsy and urease test. Outcome was the evaluation of expression and/or methylation level of a biomarker (proteins or RNA in case of expression level, and gene in case of methylation level assessment) related to gastric cancer in adults. Comparison group were children with no H. pylori infection according to the already named diagnostic methods.
Search Strategy and Study Selection
We conducted a literature search of PubMed® on December 10, 2019 using the following search terms [pylori AND children AND (cancer OR oncogene OR gastric damage)] with filters humans and English language. Titles and abstracts were screened for relevance. Studies published previous to 1999 were excluded. We first excluded manuscripts with the following designs: non-systematic reviews, systematic reviews/meta-analyses, epidemiologic studies (those including information only on prevalence and/or incidence of H. pylori infection in different contexts and/or on gastric cancer), bacterial-factor related studies, case reports, clinical guidelines, therapy or vaccine studies, diagnostic method studies, histopathology studies, animal model studies, in vitro studies, studies about microbiome, antibiotic resistance, opinion letters, replies and editorials. Articles that did not include an abstract or have full-text availability in English were also excluded. The remaining publications that included information on potential biomarkers were analyzed in-depth. Eligibility criteria were defined as: (1) studies including both H. pylori infected and non-infected children, (2) pediatric data clearly differentiated from adult data, (3) studies on biomarkers (genes and/or proteins) related to cell proliferation, gastric damage and/or cancer, and (4) studies that reported biomarker expression levels (as RNA or protein) and/or methylation level. As our focus is on carcinogenesis, articles dedicated exclusively to immune response were excluded (including articles related to polymorphisms in interleukins and innate immune genes, expression levels of proinflammatory and anti-inflammatory cytokines, and gastric infiltration or systemic levels of different immune cells). We added a direct search for the following biomarkers which were not identified in our initial literature search but known to play a role in adult carcinogenesis: pepsinogen, adhesion molecules, chemokines and gastrin. Finally, when a biomarker was selected, an additional search was performed in PubMed® (using terms pylori AND children AND “biomarker name”), applying the same exclusion criteria. Details on the search process ere depicted in Supplementary Figure S1.
Oncogenic and Gastric Damage-Related Biomarkers Identified in Children
Thirty-seven studies from 14 different countries were finally selected, involving children and adolescents from 3 months to 19 years of age. Only 1 study included patients older than 18 years (Maciorkowska et al., 2005), but median age were 10–13 years in different groups, so it was no excluded. Most studied children were symptomatic, with only 3/37 studies including asymptomatic children (Supplementary Tables S1, S2). A total of 37 molecules cataloged as biomarkers of carcinogenesis were found to be overexpressed, underexpressed and/or hypermethylated among infected children compared to non-infected controls, as detailed in Tables 1–3 respectively, and summarized in Figure 1. Biomarkers are classified by function (transcription factors, transporters and enzymes, extracellular secreted proteins, signaling protein or kinases, cell adhesion proteins, cell proliferation markers and microRNAs), as shown in Tables 1–3; details on the molecules (proteins, RNA or DNA) analyzed for each biomarker, and sample type (gastric or blood/serum) are depicted in Figure 2; details on the biological function and role in carcinogenesis can be found in Supplementary Table S3. These biomarkers are briefly described below, focusing on the information available in children.
TABLE 1
| Biomarker | No. of studies with significant upregulation (references) | Biological function | Potential role in carcinogenesis |
| β-catenin | 1 (Villarreal-Calderon et al., 2014) | Transcription factor | Oncogenic |
| BCL-2 | 1 (Ryszczuk et al., 2016) | Transporter or enzyme | Controversial |
| C-MYC | 1 (Nardone et al., 2001) | Transcription factor | Oncogenic |
| CCL18 | 1 (Ikuse et al., 2012) | Extracellular secreted protein | Controversial |
| CXCL9, 10, 11 | 1 (Ikuse et al., 2012) | Extracellular secreted protein | Controversial |
| CXCL13 | 2 (Ikuse et al., 2012; Obayashi et al., 2016) | Extracellular secreted protein | Oncogenic |
| COX2* | 1 (Kim et al., 2004) | Transporter or enzyme | Controversial |
| DC-SIGN | 1 (Wu et al., 2014) | Cell adhesion protein | Oncogenic |
| Gastrin** | 5 (Kato et al., 2004; Maciorkowska et al., 2006; Plonka et al., 2006; Czaja et al., 2008; Guariso et al., 2009) | Extracellular secreted protein | Oncogenic |
| EGFR | 2 (Maciorkowska et al., 2009; Ryszczuk et al., 2016) | Receptor | Oncogenic |
| Ki67 | 4 (Kim et al., 2004; Ozturk et al., 2005; Muñoz et al., 2007; Saf et al., 2015) | Not known | Not known |
| LCN2 | 2 (Ikuse et al., 2012; Obayashi et al., 2016) | Extracellular secreted protein | Controversial |
| p53*** | 2 (Ozturk et al., 2005; Saf et al., 2015) | Transcription factor | Anti-oncogenic |
| p21**** | 1 (Saf et al., 2015) | Signaling protein or kinases | Controversial |
| Pepsinogen I$ ***** | 8 (Fukuda et al., 2003; Rogers et al., 2003; Lopes et al., 2006; Roma et al., 2006; Guariso et al., 2009; Kassem et al., 2017; Nakayama et al., 2017; Kienesberger et al., 2018) | Extracellular secreted protein | GC biomarker |
| Pepsinogen II$ | 8 (Fukuda et al., 2003; Rogers et al., 2003; Lopes et al., 2006; De Angelis et al., 2007; Koivusalo et al., 2007; Guariso et al., 2009; Kassem et al., 2017; Nakayama et al., 2017) | Extracellular secreted protein | GC biomarker |
| PIM2 | 1 (Obayashi et al., 2016) | Signaling protein or kinases | Oncogenic |
| PPAR- Υ | 1 (Haruna et al., 2008) | Receptor | Controversial |
| REG3A | 1 (Obayashi et al., 2016) | Extracellular secreted protein | Controversial |
| miRNA-146a | 1 (Cortés-Márquez et al., 2018) | Post-transcriptional gene expression regulator | Controversial |
| miRNA-155 | 1 (Cortés-Márquez et al., 2018) | Post-transcriptional gene expression regulator | Controversial |
| VCAM-1 | 1 (Maciorkowska et al., 2005) | Cell adhesion protein | Oncogenic |
Biomarkers overexpressed in H. pylori infected children in at least one study included in this review.
*1 study shows no significant mRNA upregulation in infected children. (Haruna et al., 2008). **2 studies show no significant change in expression (Nardone et al., 2001; Villarreal-Calderon et al., 2014). ***5 studies show no significant change in expression (Fukuda et al., 2003; Roma et al., 2006; Xie et al., 2006; De Angelis et al., 2007; Koivusalo et al., 2007), and 1 study show significant downregulation (Lopes et al., 2006); as most studies agree that gastrin is upregulated, it was not included in Table 2. ****1 study published before 1999 shows no significant change in expression (Jones et al., 1997). *****2 studies show no differences in serum levels compared to non-infected controls (De Angelis et al., 2007; Koivusalo et al., 2007). $1 study shows significant downregulation in gastric tissue (Ikuse et al., 2012). As most studies agree that pepsinogen is upregulated, it was not included in Table 2. No.: Number.
TABLE 2
| Biomarker | No. of studies with significant downregulation (references) | Biological function | Potential role in carcinogenesis |
| MUC5AC | 1 (Park et al., 2015) | Extracellular secreted protein | Controversial |
| SLC5A8 | 2 (O’Ryan et al., 2015*, Orellana et al., 2016) | Transporter or enzyme | Anti-oncogenic |
| TIMP1 | 1 (Rautelin et al., 2010) | Extracellular secreted protein | Controversial |
Biomarkers underexpressed in H. pylori infected children in at least one study included in this review.
No.: Number. *Microarray results published by O’Ryan et al., are included as they were checked by qRT-PCR by Orellana et al.
TABLE 3
| Biomarker | No. of studies with significant hypermethylation (references) | Biological function | Potential role in carcinogenesis |
| CALCA | 1 (Shin et al., 2011) | Extracellular secreted protein | Controversial |
| CDH1 | 1 (Shin et al., 2011) | Cell adhesion protein | Anti-oncogenic |
| CRABP1 | 1 (Shin et al., 2011) | Receptor | Controversial |
| DAPK1 | 1 (Shin et al., 2011) | Transporter or enzyme | Anti-oncogenic |
| GATA-4 | 1 (Alvarez et al., 2013a) | Transcription factor | Anti-oncogenic |
| GATA-5 | 1 (Alvarez et al., 2018) | Transcription factor | Anti-oncogenic |
| GRIN2B | 1 (Shin et al., 2011) | Receptor | Anti-oncogenic |
| THBS1 | 1 (Alvarez et al., 2013a) | Extracellular secreted protein | Controversial |
| TIMP3 | 1 (Shin et al., 2011) | Extracellular secreted protein | Anti-oncogenic |
| TWIST1 | 1 (Shin et al., 2011) | Transcription factor | Controversial |
Biomarkers hypermethylated in H. pylori infected children in at least one study included in this review.
No.: Number.
FIGURE 1
FIGURE 2
Biomarkers Classified by Biological Function
Transcription Factors
Six transcription factors have been identified as differentially expressed or methylated in H. pylori infected children at the protein or gene level, three of which have been reported to be overexpressed (p53, β-catenin and C-MYC) and three hypermethylated (TWIST-1, GATA-4, and GATA-5).
p53 is a human tumor suppressor gene, whose expression is constitutively low in healthy tissue and increases in response to DNA damage or other types of cellular stress (Bieging et al., 2014). Inactivation and accumulation of p53 is a hallmark of carcinogenesis, including GC, in which higher p53 levels in malignant tissue are associated with poor prognosis (Yildirim et al., 2015; Zhou et al., 2016). H. pylori induction of p53 expression has been described in chronic gastritis and preneoplasic lesions (such as intestinal, metaplasia and dysplasia in adults), especially those associated with CagA-positive strains (Teh et al., 2002; Li et al., 2016). Pediatric studies assessed in this review showed contradictory results, with p53 overexpressed in gastric tissue of H. pylori infected children, and directly correlated with gastritis, the magnitude of inflammatory cell infiltration and H. pylori tissue density in two studies (Ozturk et al., 2005; Saf et al., 2015); while on the other hand two other studies showed similar expression levels in infected and non-infected children (Nardone et al., 2001; Villarreal-Calderon et al., 2014).
β-catenin acts as a transcriptional regulator in the Wnt signaling pathway (Ebert et al., 2003; Chiurillo, 2015). H. pylori promotes the Wnt/β-catenin pathway through several mechanisms: by upregulating Wnt/β-catenin activators, c-Met and EGFR, by downregulating the Wnt/β-catenin suppressors, TFF1 and RUNX3, and also by recruiting tumor-associated macrophages (Song et al., 2015). Villarreal – Calderón et al., describe high membranous expression of β-catenin in gastric biopsies of H. pylori infected children as compared to non-infected controls (Villarreal-Calderon et al., 2014).
C-MYC belongs to Myc family of oncogenes (derived from myelocytomatosis viral oncogene). C-MYC is overexpressed in GC compared to normal tissue, and its expression levels are correlated with metastasis and lower survival rates (Zhang et al., 2010; Khaleghian et al., 2015). H. pylori gastritis in adults is associated with overexpression of C-MYC (Nardone et al., 1999), and according to Nardone et al. (2001) is also overexpressed in the gastric tissue of infected children, regardless of CagA status, and is associated with high cell proliferation.
TWIST-1 (coding twist-related protein 1) is involved in epithelial-mesenchymal transition and cell-migration processes, and is overexpressed in several human cancers, including GC (Yang et al., 2007; Izadpanah et al., 2017). However, TWIST-1 is hypermethylated in GC and other neoplasms (Gort et al., 2008; Kang et al., 2008; Sakamoto et al., 2015), so its functional significance remains unknown. Hypermethylation has been previously described in gastric mucosa of H. pylori infected children and adults (Shin et al., 2011).
GATA-4 and 5 belongs to the GATA family of transcription factors (name derived from DNA consensus sequence to which it binds). Both are cancer suppressor genes involved in cell-differentiation, and the silencing of both GATA-4 and GATA-5 by hypermethyation has been identified in several tumors, including GC (Akiyama et al., 2003; Wen et al., 2010). Furthermore, GATA-4 hypermethylation has been described in intraepithelial neoplasia, gastric dysplasia and H. pylori infected tissue in adults (Wen et al., 2010). Alvarez et al. (2013a) demonstrated GATA-4 hypermethylation in pediatric and adult H. pylori-induced gastritis, correlating with low expression levels compared to unmethylated samples, however, in GC samples its downregulation was not related to methylation levels. Later, the same group showed GATA-5 hypermethylation in gastric tissue of children and adults infected by H. pylori, however, mRNA expression tended to be higher in unmethylated infected tissue compared to non-infected samples, postulating that an initial protective effect of the mucosa in response to infection. Hypermethylation and downregulation was consistently shown in GC samples (Alvarez et al., 2018).
Transporters and Enzymes
Four biomarkers identified in this review are classified as transporters or enzymes, two of which have been reported as overexpressed (Bcl-2, COX2), one underexpressed (SLC5A8) and one as hypermethylated (DAPK1).
Bcl-2 (B-cell lymphoma-2) belongs to the intrinsic apoptotic pathway, and H. pylori infection is associated with over expression of both the Bcl-2 (which codifies the main anti-apoptotic protein) and Bax genes (pro-apoptotic), with Bax expression predominating in chronic gastritis and Bcl-2 expression in GC. This suggests that disturbances in the balance between Bax and Bcl-2 contribute to H. pylori induced carcinogenesis (Bartchewsky et al., 2010). In GC, Bcl-2 is overexpressed, especially in H. pylori- associated adenocarcinoma, however, while several studies have assessed the relationship between Bcl-2 expression and prognosis in GC, results have been inconsistent. Additionally, according to a recent meta-analysis, Bcl-2 could be a favorable prognostic marker in Asian populations (Zhang et al., 2004; Cheng et al., 2015; Zhou et al., 2015). These results are in agreement with other studies showing that Bcl-2 not only inhibits apoptosis, but also suppresses cellular proliferative activity (Bélanger et al., 2005). According to Ryszczuk et al. (2016) Bcl-2 is over expressed in antral gastritis of H. pylori infected children, in both surface epithelial and gland cells.
COX-2 (Cyclooxygenase 2) is an enzyme which catalyzes prostaglandin synthesis (Vane et al., 1998). It is over expressed in H. pylori- infected gastric epithelium, and this over expression is correlated with the presence of severe metaplasia, atrophy and dysplasia (Badary et al., 2017). Expression of the COX-2 gene is significantly increased in human gastric adenocarcinoma tissue as compared to paired gastric mucosal specimens devoid of cancer cells; potential mechanisms for carcinogenesis are apoptosis inhibition, maintenance of cell proliferation and stimulation of angiogenesis in cancer cells (Nuñez et al., 2011). Over expression of COX-2 protein in H. pylori infected children, mainly in monocytic cells and myofibroblasts of gastric tissue, was detected and positively correlated with acute and chronic gastric inflammation in one study (Kim et al., 2004). Later, Haruna et al. (2008) showed higher levels of COX-2 mRNA in gastric tissue of infected compared to non-infected children; difference although were not statistically significant, and expression levels were not associated to presence of ulcers.
SLC5A8 (solute carrier family 5 member 8) is a short chain fatty acid transporter that is underexpressed in several human tumors, including GC (Ueno et al., 2004; Ganapathy et al., 2008; Brim et al., 2011). H. pylori infection is associated with SLC5A8 underexpression in gastric tissue in symptomatic children and in serum samples in asymptomatic children (Orellana et al., 2016), but expression levels in cancer free infected adults have not been explored.
DAPK1 (death associated protein kinase 1) is a kinase protein with pro-apoptotic function in normal tissue; it is described to be hypermethylated in GC tissue compared to normal tissue, which is associated with poor survival (Yao et al., 2012). Hypermethylation was also reported in gastric tissue of H. pylori infected children (Shin et al., 2011), however, methylation levels were higher in infected adults, suggesting an age-related methylation effect.
Extracellular Secreted Proteins
Fifteen extracellular secreted proteins have been described as possible biomarkers in H. pylori infected children, ten of which were overexpressed (CCL18, CXCL9, CXCL10, CXCL11, CXCL13, LCN2, REG3A, Gastrin, PGI, and PGII), two underexpressed (MUC5AC, TIMP1), and three hypermethylated (CALCA, THBS1, and TIMP3).
CCL18 (C-C Motif Chemokine Ligand 18) is a chemokine involved in migration and activation of leucocytes; it is overexpressed in several cancer tissues, including GC (Schutyser et al., 2005), and is associated with tumor metastasis, as recently reviewed (Huang et al., 2018). It promotes activation of the ERK/NFKB signaling pathway (Hou et al., 2016), suggesting an oncogenic role, which differs from previous reports (Leung et al., 2004). CXCL9, CXCL10, and CXCL11 (C-X-C motif chemokine ligand 9, 10, and 11, respectively) are chemokines that share functions as ligands of CCR3, stimulating antitumoral immunity, but they can also promote proliferation and metastasis in cancer cells in an autocrine pathway, as recently reviewed (Tokunaga et al., 2018). In vitro data show that CXCL9, 10, 11/CCR3 axis promote tumor immune-evasion by stimulating expression of the programmed death-ligand 1 (PDL1) in GC cells (Zhang et al., 2018). Overexpression of CXCL9 and 10 is found in GC tissue compared to normal gastric tissue (Raja et al., 2017), however, data on CXCL11 expression in GC was not found. CXCL13 (C-X-C motif chemokine ligand 13) is related to cell proliferation and associated with poor prognosis in several neoplasms, including GC (Fan et al., 2017; Wei et al., 2018). Obayashi et al. (2016) showed CXCL13 overexpression primarily around lymphoid follicles in gastric biopsies from infected children; while Ikuse et al. (2012) showed overexpression of CXCL9, 10, 11, 13, and CCL18 in gastric tissue of infected children, all of whom had histological inflammation and nodular gastritis.
LCN2 (lipocalin 2) is a secreted glycoprotein involved in innate immune response, and its role in GC is controversial; in adults it is overexpressed in gastritis mucosa infected with H. pylori, but not in mucosa with intestinal metaplasia, dysplasia or GC (Alpízar-Alpízar et al., 2009). Wang et al. (2010) described that LCN2 overexpression in GC is associated with low survival. Obayashi et al. (2016) postulated that LCN2 overexpression due to H. pylori infection in children, demonstrated both in epithelial cells and inflammatory cells in gastric epithelium, may interfere with iron uptake and proliferation of the bacterium, thereby protecting infected gastric mucosa from carcinogenesis.
REG (Regenerating islet-derived) proteins have an anti-apoptotic role in gastric tissue (Parikh et al., 2012), and their overexpression in H. pylori infected gastric mucosa is associated with neutrophil activity and chronic inflammation (Yoshino et al., 2005). REG3A, a member of this family, is overexpressed in GC, and promotes the proliferation, migration, invasion and adhesion of GC cells by regulating the JAK2/STAT3 signal pathway (Chen et al., 2017). However, previous reports showed under expression of REG3A in primary GC and GC cell lines (Choi et al., 2007). Obayashi et al. (2016) showed overexpression of REG3A in inflammatory cells in lamina propia, but not epithelial cells of gastric epithelium, in both infected children and adults, which reflects a role in chronic gastritis.
MUC5AC (mucin 5AC) is a secreted mucin underexpressed in epithelial neoplasms (Corfield et al., 2001). A recent meta-analysis describes that H. pylori infection is associated with lower MUC5AC expression in the gastric epithelium compared to non-infected patients (Niv, 2015). Furthermore, MUC5AC is underexpressed in GC tissue compared to healthy tissue, and its decreased expression is associated with more aggressive tumor behavior (Javanbakht et al., 2017). However, MUC5AC expression in other tissues, such as lung and pancreas, induces cell proliferation and migration, acting as a pro-oncogenic factor (Yamazoe et al., 2010; Lakshmanan et al., 2016). In children, its expression is lower in H. pylori infected mucosa compared to non-infected samples, specifically in children >5 years of age (Park et al., 2015).
Matrix metalloproteinase (MMPs) are involved in tumor invasion, and their activity is regulated by inhibitors such as tissue inhibitor metalloproteinase-1 (TIMP1) (Kessenbrock et al., 2010). However, pro-oncogenic functions of TIMP proteins have been described (Jackson et al., 2017). TIMP1 expression is up regulated in GC, with tumor-associated myofibroblasts acting as the main source of increased TIMP1 expression locally (Alpízar-Alpízar et al., 2016). Also, elevated protein levels in tumor tissue and plasma from GC patients are associated with poor outcomes (Grunnet et al., 2013). However, as reviewed here, H. pylori infection in children is associated with decreased serum expression of TIMP1 (Rautelin et al., 2010), which conflicts with previously exposed data in adults and requires further study.
In contrast to TIMP1, evidence suggests that TIMP3 has an anti-oncogenic function (Anand-Apte et al., 1996; Ahonen et al., 1998). Increased methylation and lower expression levels have been shown in GC compared to normal gastric tissue; a direct relationship between methylation levels, lymph node metastasis and more advanced cancers has also been described (Yao et al., 2012; Guan et al., 2013). The hypermethylation of TIMP3 in infected children (Shin et al., 2011) may reflect the beginning of a downregulation process.
CALCA (calcitonin related polypeptide alpha), codifies procalcitonin and procalcitonin-related peptides, precursors of calcitonin, a regulator of calcium homeostasis. It is over expressed in lung and medullar thyroid carcinomas, also playing a relevant role in T-cell and B-cell regulation in these malignancies (El Hage et al., 2008). CALCA hypermethylation has been described in several hematological and solid tumors, including GC, and is associated with a poor prognosis (Paixão et al., 2006; Yao et al., 2012; Martinelli et al., 2016). Gastric hypermethylation of CALCA has been described in H. pylori infected children (Shin et al., 2011).
THBS1 (Thrombospondin 1) is a matrix glycoprotein with controversial role in cancer, with some reports showing an antioncogenic function, and others a pro-oncogenic role (Grossfeld et al., 1997; Maeda et al., 2001; Kazerounian et al., 2008). Specifically in GC, decreased THBS1 expression has been associated with a poor prognosis (Eto et al., 2015), but higher expression in cancer tissue has been correlated with cell invasion and migration (Huang et al., 2017). Alvarez et al. (2013a) describe hypermethylation of THBS1 in gastric tissue of infected adults and children. Expression level in unmethylated samples was higher in infected children, however, comparison of expression level in total samples between infected and not infected children is not shown. In gastric cancer tissue, meanwhile, its downregulation was not associated with methylation levels (Alvarez et al., 2013a). Thus, the role of THBS1 in carcinogenesis is controversial, and its hypermethylation in H. pylori infected children (Alvarez et al., 2013a) may or may not be related to future carcinogenesis in gastric tissue.
Pepsinogens (PGs) I and II are precursors of pepsin, produced in gastric cells, and in case of PGII, also by duodenal cells (Samloff, 1971; Samloff and Liebman, 1973). Because they are secreted to the gastric lumen, PGI and II are currently used as serum biomarkers of the functional and anatomical integrity of gastric mucosa (Shiota and Yamaoka, 2014). In H. pylori-induced gastritis, both PGI and II are upregulated, with a greater increase in PGII and a consequent decrease in the PGI/II ratio (Kim and Jung, 2010). Changes in PG expression during infection are caused by gastric inflammation and by direct stimulation of H. pylori lipopolysaccharides on gastric cells, and are reversed after eradication treatment (Young et al., 2002). A decrease in PGI, PGII and the PGI/II ratio occurs in atrophic gastritis and GC, as extensively reviewed (Huang et al., 2015). In children, expression of PGI and II in gastric tissue of infected children has been reported to increase at the protein level (Roma et al., 2006) and decrease at the mRNA level (Ikuse et al., 2012). However, various studies have shown a consistent increase in serum PGII in both symptomatic (Lopes et al., 2006; De Angelis et al., 2007; Koivusalo et al., 2007; Guariso et al., 2009; Kassem et al., 2017) and asymptomatic (Fukuda et al., 2003; Rogers et al., 2003; Nakayama et al., 2017) infected children. In case of PGI, most studies show serum overexpression in both symptomatic and asymptomatic infected children (Fukuda et al., 2003; Rogers et al., 2003; Lopes et al., 2006; Roma et al., 2006; Guariso et al., 2009; Kassem et al., 2017; Nakayama et al., 2017; Kienesberger et al., 2018); but 2 studies reported no difference between infected and non-infected children (De Angelis et al., 2007; Koivusalo et al., 2007). However, De Angelis et al. (2007) reported serum overexpression specifically among infected children older than 10 years, while Koivusalo et al. (2007) included mostly younger children than other studies. Thus, an age-dependant induction in PGI, as reported in cohort studies (Pérez-Pérez et al., 2003) could potentially explain this variability in case-control results.
Gastrin is a peptide hormone produced by gastrointestinal cells, in a process involving several intermediates forms of which Gastrin 17, an intermediate form generated from preprogastrin, is the most abundant circulating form (Smith et al., 2017). It is responsible for initiating gastric acid release in the stomach in response to stimulus. During gastric cancer development, atrophic gastritis and hypergastrinemia have been proposed to be critical factors for both diffuse type and intestinal types of GC (reviewed in Waldum et al., 2017), by stimulating cell proliferation and other mechanisms not completely elucidated (Copps et al., 2009; Smith et al., 2017; Waldum et al., 2017). In children, serum gastrin and gastrin 17 have been reported to be overexpressed in H. pylori infected children in five studies included in this review (Kato et al., 2004; Maciorkowska et al., 2006; Plonka et al., 2006; Czaja et al., 2008; Guariso et al., 2009). On the other hand, five studies (Fukuda et al., 2003; Roma et al., 2006; Xie et al., 2006; De Angelis et al., 2007; Koivusalo et al., 2007) showed no differences in gastrin or gastrin 17 serum or gastric levels according to infectious status. Most studies [with the exception of Plonka et al. (2006) and Fukuda et al. (2003)] were performed in symptomatic children. One study (Lopes et al., 2006) showed lower gastrin levels among infected symptomatic children compared to controls.
Receptors
Four biomarkers highlighted here have a primary biological function as receptors: EGFR and PPAR-Y (overexpressed in H. pylori infected individuals), CRABP2 (hypermethylated), and GRIN2B (hypermethylated).
EGFR (epidermal growth factor receptor) is involved in cell proliferation signaling (Wee and Wang, 2017). In gastric cell lines and animal models, H. pylori induces EGFR expression and activation through phosphorylation; EGFR inhibition downregulates H. pylori-induced epithelial inflammatory responses, such as DNA damage and gastric carcinogenesis (Keates et al., 2007; Kim et al., 2013; Sierra et al., 2017). In humans, EGFR is over expressed in GC compared with normal gastric tissue and correlates with poor prognosis (Gao et al., 2013; Petrini et al., 2017). Therefore, anti-EGFR agents have been evaluated for treatment of advanced GC, with variable results between studies, and no overall benefit according to a recent meta-analysis (Kim et al., 2017). In infected children, EGFR is overexpressed mainly in epithelial gastric cells (Maciorkowska et al., 2009; Ryszczuk et al., 2016).
CRABP1 (Cellular retinoic acid-binding protein 1) is responsible for binding retinoic acid transporting it into cells. Evidence for its role in carcinogenesis is controversial, showing both pro-apoptotic and pro-metastatic properties in vitro (Kainov et al., 2014; Persaud et al., 2016). Its hypermethylation and/or underexpression has been described in colorectal, breast, ovarian, esophageal and cervical cancers (Tanaka et al., 2007; Miyake et al., 2011; Liu et al., 2015; Arellano-Ortiz et al., 2016; Cha et al., 2016). However, to our knowledge there is no evidence as to the role of its expression or methylation status in GC, making the finding of its H. pylori-mediated hypermethylation in children, described by Shin et al. (2011) unclear.
GRIN2B (Glutamate Ionotropic Receptor NMDA Type Subunit 2B) codifies for a glutamate receptor expressed on the surface of cancer cells (Deutsch et al., 2014), and its hypermethylation and silencing have been reported in several solid tumors, including GC (Kim et al., 2006; Liu et al., 2007; Kang et al., 2008; Tamura et al., 2011). In GC, H. pylori infection showed no significant correlation with GRIN2B hypermethylation (Kang et al., 2008). Shin et al. (2011) described the hypermethylation of both CRABP1 and GRIN2B in gastric tissue of H. pylori infected children compared to non-infected controls. Furthermore, samples from infected adults showed higher methylation than infected children (Shin et al., 2011), suggesting an age-related methylation effect in long-term infections, which may be related to future carcinogenesis.
PPAR-Υ (Peroxisome proliferator-activated receptor gamma) is a nuclear hormone receptor, which also acts as a transcription factor regulating expression of genes involved in metabolism and cell proliferation. Depending on the cell context, it can act as antiproliferative and antitumorigenic, or antiapoptotic and oncogenic (Vella et al., 2017). In gastric tissue, overexpression has been described in GC and dysplasia compared to gastritis (Yao et al., 2010), but treatment with PPAR-Υ agonist inhibits cell proliferation (Sato et al., 2000). Other studies have described downregulation in GC and association with survival (Yu and Xin, 2013). In children, overexpression of PPAR-Υ mRNA has been described in gastric tissue of infected children compared to non-infected controls (Haruna et al., 2008), but because its role in GC is not clear, the relative importance of its overexpression in children requires further analysis.
Signaling Proteins or Kinases
p21 is classically defined as a tumor suppressor protein, however, it is generally overexpressed in cancer tissue, and there is increasing evidence that p21 plays an oncogenic role (Georgakilas et al., 2017). In GC tissue, p21 is overexpressed and its expression has also been associated with poor prognosis (Luo et al., 2014; Altun et al., 2015). H. pylori infection in in vitro models are correlated with p21 overexpression (Xia et al., 2008); in the pediatric population Saf et al. (2015) described the overexpression of p21 in gastric tissue of H. pylori infected children, however, in a study published before the date range stated in our search strategy (not included in tables) gastric expression was comparable to non-infected children (Jones et al., 1997), showing contradictory results in children.
PIM2 (proviral integration site of Moloney virus) is a kinase with anti-apoptotic function in vitro (Blanco-Aparicio and Carnero, 2013), and its overexpression has been described mainly in hematologic neoplasms, such as multiple myeloma, as well as in solid tumors, such as colorectal and liver carcinomas (Gong et al., 2009; Zhang et al., 2015; Ramachandran et al., 2016). Recently, PIM2 overexpression associated with poor prognosis has been described in GC, related with suppression of reactive oxygen species and endoplasmic reticulum stress mediated apoptosis (Xin et al., 2018). In children, PIM2 is overexpressed in gastric epithelium of H. pylori infected children (Obayashi et al., 2016).
Cell-Adhesion Proteins
CDH1 (cadherin 1) has cell adhesion as a primary function and hypermethylation has been described in both GC (Zazula et al., 2006) and in relation to H. pylori infection; furthermore, its hypermethylation is reversed following eradication therapy (Choi et al., 2016). Shin et al. (2011) describe H. pylori-associated hypermethylation in gastric tissue of children, at levels similar to adults.
VCAM-1 (Vascular Cell Adhesion Molecule 1) overexpression is related to angiogenesis and metastasis in cancer, including GC (Kong et al., 2018); in which both local expression in gastric tissue and serum levels are directly associated with poor prognosis (Velikova et al., 1997; Ding et al., 2003). In children, Maciorkowska et al., described that serum concentrations of VCAM-1 were higher in symptomatic children with H. pylori-associated gastritis compared to non-infected children; they also compared children with positive IgG against H. pylori but with no active gastric infection (Maciorkowska et al., 2005), showing that serum levels of VCAM-1 correlate with H. pylori-induced gastric inflammation and damage.
DC-SIGN (Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin) is a lectin that can act as a pattern recognition receptor, recognizing carbohydrates from microorganisms, for initiation of the immune response. In addition, it can mediate cell migration and adhesion of dendritic cells, and in cancer, it can mediate immune escape of tumor cells. Expression of DC-SIGN is normally low in gastric tissue, being overexpressed in gastric cancer (Domínguez-Soto et al., 2011), where it promotes proliferation, cell cycle progression, migration and invasion of GC cells in vitro (Li et al., 2020). In children, DC-SIGN is overexpressed in gastric tissue of H. pylori infected children, which has been directly correlated with the magnitude of inflammation (Wu et al., 2014); this correlates with in vitro results, showing that H. pylori induces DC-SIGN expression in gastric epithelial cells and a Th1 immune response (Wu et al., 2014). Although this reflects epithelial immune response against the pathogen, its relevance in future carcinogenesis needs to be elucidated.
Cell Proliferation Markers
Ki-67 is widely used as a cell proliferation marker (Li et al., 2015), but its function in carcinogenesis is not clear. Ki-67 is overexpressed in intestinal metaplasia and GC tissue compared to healthy tissue, but has not shown a clear prognostic value in GC (Zheng et al., 2010; Böger et al., 2016). Its expression is also increased in H. pylori infected mucosa in adults (Sagheb et al., 2016), with concordant results in all pediatric studies reviewed here. Overexpression of Ki67 in gastric tissue of infected children is indicative of proliferative activity, extending to surface epithelium, which is not observed in non-infected controls (Muñoz et al., 2007). Gastric Ki67 expression in infected children is positively correlated with acute and chronic inflammatory infiltrating cells (Kim et al., 2004; Ozturk et al., 2005; Muñoz et al., 2007), intestinal metaplasia and glandular atrophy (Kim et al., 2004) and H. pylori density (Kim et al., 2004; Ozturk et al., 2005; Saf et al., 2015).
Micro RNAs
Two microRNAs, involved in post-transcriptional gene expression regulation are significantly overexpressed in gastric tissue of symptomatic infected children. miRNA-146a and miRNA-155 have been described as downregulated in GC (Hou et al., 2012; Li et al., 2012), but also as a potential oncogenes in vitro (Shomali et al., 2017; Qu et al., 2018). Cortés-Márquez et al. (2018) described higher gastric expression in both miRNAs in children, especially in those with severe gastritis, as observed in adults and in animal models. Because their role in carcinogenesis is controversial, further studies are needed to determine the potential role of overexpression among infected children.
Biomarkers Identified in Symptomatic Versus Asymptomatic Infected Children
Only 4/37 biomarkers identified in this review were assessed in asymptomatically infected children (SLC5A8, PGI, PGII, and gastrin); all four were evaluated in blood or serum samples, as upper endoscopies are not performed in this group. SLC5A8, PGI, and PGII were also evaluated in gastric tissue of symptomatic children, showing comparable results (except for PGI and PGII mRNA expression in gastric tissue, as commented before). These finding suggest that gastric damage can occurs among infected children not only when symptoms become evident, but also in apparently healthy children. For gastrin, reported results seem controversial as expression in gastric tissue of symptomatic children was increased (Lopes et al., 2006) while serum levels were decreased in asymptomatic children (Plonka et al., 2006).
Discussion
In this extensive review we identified 37 molecules, previously detected in adults with cancer, differentially expressed and/or methylated, in gastric tissue and/or blood/serum of H. pylori infected children, when compared to non-infected controls. Based on our review, we propose that 13 of these biomarkers require special attention, due to the concordance between expression and/or methylation status in infected children, data in adults (with H. pylori-induced gastritis and gastric cancer) and their consistent role in carcinogenesis (Tables 1–3): β-catenin, C-MYC, GATA-4, DAPK1, CXCL13, DC-SIGN, TIMP3, EGFR, GRIN2B, PIM2, SLC5A8, CDH1, and VCAM-1. Six of them (β-catenin, C-MYC, CXCL13, DC-SIGN, EGFR, and PIM2) are consistently described as oncogenes according to the literature, and are overexpressed at the protein or mRNA level in gastric tissue among infected children and gastric cancer patients. VCAM-1, a molecule described as an oncogene in adults, is overexpressed in serum of children with H. pylori-induced gastritis, representing a potential non-invasive biomarker of H. pylori-induced damage in both symptomatic and asymptomatic children. Five molecules (DAPK1, TIMP3, GRIN2B, SLC5A8, and CDH1) are tumor suppressor genes consistently downregulated and/or hypermethylated in GC and in H. pylori infected children. The fact that genes or proteins with a known oncogenic or antioncogenic function have a consistent dysregulation in H. pylori infected children, suggests a pathogenic role of infection during early stages, and supports the evaluation of treatment and/or follow-up strategies for infected children, even in absence of symptoms, due to their potential long-term consequences.
Pepsinogen I and II have no described oncogenic effect at the cellular or molecular level, but they reflect integrity of gastric mucosa; overexpression at the protein level in serum of infected children, consistent with data of H. pylori induced gastritis in adults, suggests that these biomarkers can be useful for determining gastric damage or inflammation induced by H. pylori in children. However, according to studies reviewed here, even though elevated serum pepsinogens levels predicts H. pylori infection (De Angelis et al., 2007; Guariso et al., 2009), they have not always correlated with histological gastritis (Lopes et al., 2006). The use of these proteins as seric biomarkers of gastric damage in asymptomatically infected children should be prospectively studied, as the levels are age-dependant.
Overexpression of gastrin is an important factor in the development of gastric cancer as discussed here. Despite the lack of consensus in studies reviewed here on the role of overexpression among infected compared to non-infected children, prospective and long term studies are needed to determine if persistent infection produces sustained hypergastrinemia and possible carcinogenesis as children progress toward older ages.
The overexpression of Ki67 in infected children, a proliferation marker with an unknown function in carcinogenesis, may represent an early biomarker of gastric carcinogenesis, but may also only reflect high levels of cell proliferation during an inflammatory process, however, this could also be considered a reflection of the pathogenesis of H. pylori infection since childhood, and its implication on future pathogenesis, together with PGI, PGII and gastrin should be explored further.
p53 has a well known antioncogenic function however, its overexpression has been demonstrated in gastric cancer during preneoplasic stages, and also in H. pylori-infected children as commented before, though there is no consensus in studies reviewed here. While it remains unclear whether this accumulated protein is inactivated, it may constitute a valuable early biomarker of bacteria-induced, chronic gastric inflammation and potential carcinogenesis.
Another group of biomarkers identified in this review have contradictory functions in cancer development, however, they are consistently overexpressed (COX2, CCL18, CXCL9, CXCL10, CXCL11), underexpressed (MUC5AC) or hypermethylated (TWIST-1) in H. pylori-infected children and adults with H. pylori-induced gastritis and/or GC. This suggests that despite an unclear role in carcinogenesis, they are associated with gastric damage and GC in adulthood, and their demonstrated dysregulation in infected children should be prospectively explored, as they could represent either transitory molecular changes associated with infection and inflammatory response and/or early changes in the natural history of gastric damage during long-term infections.
Lastly, a group of molecules differentially expressed in H. pylori infected children lack sufficient evidence as to either their role in gastric damage in adults with H. pylori- induced gastritis or GC (BCL-2, LCN2, REG3A, CALCA, THBS1, CRABP1, PPAR-Y) or dysregulation in adulthood is contradictory with findings in children (miRNA146a, miRNA155, TIMP1). Additionally, in the case of p21, there is disagreement in its expression levels in H. pylori infected children. Taken together, this group of molecules and their expression over time require more in depth studies in order to include them as potential biomarkers of early oncogenic gastric damage in H. pylori infected children.
The fact that various genes and proteins involved in GC are significantly underexpressed, overexpressed or hypermethylated in H. pylori infected children underscores the possibility that chronic infection in children, even if asymptomatic, is causing the development of a progressive malignant disease in a subset of children to be manifested later in life. However, understanding the dynamics and natural history of H. pylori infection in children remains to be fully elucidated. As recently reviewed, most of the epidemiological studies on H. pylori infection in children are cross-sectional, thus lacking information on persistence or spontaneous clearance of the infection (Zabala Torrres et al., 2017). Importantly, the main limitation of this review lies in that all the included studies have a cross-sectional design, some of them with low number of subjects; thus whether changes in gene expression generated by H. pylori infection endure in persistently infected children, and how these changes impact clinical outcomes needs to be explored further. A few studies have assessed how eradication therapy affects gene expression in H. pylori infected adults, showing a significant decrease in p53, MDM2 (Multiple double minute 2), C-MYC, Ki-67 and cyclin D1 expression in gastric tissue following eradication therapy (Kodama et al., 2005; Alshenawy and Alshafey, 2009; Triantafyllou et al., 2016). However, to our knowledge there are no published studies evaluating gene expression both pre- and post-eradication therapy in children.
Conclusion
We have summarized and discussed a number of studies indicating that early H. pylori infection during childhood may generate differences in the expression and methylation of genes potentially involved in carcinogenesis, which could be affecting the risk of gastric damage or even future GC development. At the moment it is not possible to assure that modified expression levels and/or methylation could be used as biomarkers for a predisposition to GC in adulthood. The role of many of these biomarkers in carcinogenesis is controversial, involving broad biological functions related to immune response, cell cycle, and apoptosis. Also, in case of biomarkers studied in gastric tissue, site of sampling (antrum vs. corpus) may differ between adult and child patients. These specific roles may be altered in both oncogenic processes and chronic inflammation, as they are closely related to gastric damage pathogenesis (Kalisperati et al., 2017). Several factors not detailed in this review, including environmental stimulus, gastric and/or intestinal microbiome profiles, bacterial virulence factors and host genetic polymorphisms in genes related to innate or adaptive immunity may influence not only the risk of H. pylori persistence in childhood, but probably also whether biomolecular changes determine gastric damage and/or future carcinogenesis (Figure 3; Haley and Gaddy, 2015; Alarcón et al., 2017). Long-term observational studies on infected and non-infected children are necessary to assess the spontaneous evolution of gene expression and methylation, and the response to eradication therapy. Furthermore, more in-depth screening of these molecules is required, in order to clarify their role in the development of chronic infection and in future outcomes of infection. In the meantime, this review should aid researchers in selecting the most suitable targets in the quest for potentially useful biomarkers of future GC risk in H. pylori infected children.
FIGURE 3
Statements
Author contributions
SG and MO’R conceived the original idea. SG performed literature search and study selection. SG and MO’R wrote the manuscript with substantial support from YL, JT, and AL. All authors approved the final manuscript.
Funding
This work was supported by the Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) 1170451.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2020.00090/full#supplementary-material
References
1
AhnH. J.LeeD. S. (2015). Helicobacter pylori in gastric carcinogenesis.World J. Gastrointest. Oncol.7455–465. 10.4251/wjgo.v7.i12.455
2
AhonenM.BakerA. H.KähäriV. M. (1998). Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.Cancer Res.582310–2315.
3
AkelmaA. Z.AbaciA.OzdemirO.CelikA.AvciZ.RaziC. H.et al (2012). The association of serum lipocalin-2 levels with metabolic and clinical parameters in obese children: a pilot study.J. Pediatr. Endocrinol. Metab.25525–528. 10.1515/jpem-2011-0477
4
AkiyamaY.WatkinsN.SuzukiH.JairK.-W.van EngelandM.EstellerM.et al (2003). GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.Mol. Cell. Biol.238429–8439. 10.1128/MCB.23.23.8429-8439.2003
5
AlarcónT.LlorcaL.Perez-PerezG. (2017). Impact of the microbiota and gastric disease development by Helicobacter pylori.Curr. Top. Microbiol. Immunol.400253–275. 10.1007/978-3-319-50520-6_11
6
Alpízar-AlpízarW.LaerumO. D.ChristensenI. J.OvreboK.SkarsteinA.Høyer-HansenG.et al (2016). Tissue inhibitor of metalloproteinase-1 is confined to tumor-associated myofibroblasts and is increased with progression in gastric adenocarcinoma.J. Histochem. Cytochem.64483–494. 10.1369/0022155416656173
7
Alpízar-AlpízarW.LaerumO. D.IllemannM.RamírezJ. A.AriasA.Malespín-BendañaW.et al (2009). Neutrophil gelatinase-associated lipocalin (NGAL/Lcn2) is up regulated in gastric mucosa infected with Helicobacter pylori.Virchows Arch.455225–233. 10.1007/s00428-009-0825-8
8
AlshenawyH.AlshafeyA. (2009). Eradication of Helicobacter pylori decreases the expression of p53 and c-Myc oncogenes.Arab J. Gastroenterol.10146–150. 10.1016/j.ajg.2009.10.003
9
AltunE.CalikM.DemirciE.DaloglucF. (2015). The expressions of p16 and p21 to predict the clinicopathological behavior and prognosis of gastric cancer.J. Exp. Clin. Med.32151–157. 10.5835/jecm.omu.32.04.003
10
AlvarezM. C.FernandesJ.MichelV.TouatiE.RibeiroM. L. (2018). Effect of Helicobacter pylori infection on GATA-5 and TFF1 regulation, comparison between pediatric and adult patients.Dig. Dis. Sci.632889–2897. 10.1007/s10620-018-5223-0
11
AlvarezM. C.LadeiraM. S.ScaletskyI. C.PedrazzoliJ.Jr.RibeiroM. L. (2013a). Methylation pattern of THBS1, GATA-4, and HIC1 in pediatric and adult patients infected with Helicobacter pylori.Dig. Dis. Sci.582850–2857. 10.1007/s10620-013-2742-6
12
AlvarezM. C.SantosJ. C.ManiezzoN.LadeiraM. S.da SilvaA. L.ScaletskyI. C.et al (2013b). MGMT, and MLH1 methylation in Helicobacter pylori-infected children, and adults.World J. Gastroenterol.193043–3051. 10.3748/wjg.v19.i20.3043
13
Anand-ApteB.BaoL.SmithR.IwataK.OlsenB. R.ZetterB. (1996). A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth.Biochem. Cell Biol.74853–862. 10.1139/o96-090
14
Arellano-OrtizA. L.Salcedo-VargasM.Vargas-RequenaC. L.López-DíazJ. A.De la Mora-CovarrubiasA.Silva-EspinozaJ. C.et al (2016). DNA methylation of cellular retinoic acid-binding proteins in cervical cancer.Genet. Epigenet.853–57. 10.4137/GEG.S40847
15
BadaryD. M.RahmaM. Z. A. A.AshmawyA. M.HafezM. Z. (2017). H. pylori infection increases gastric mucosal COX2 and mTOR expression in chronic gastritis: implications for cancer progression?Pathophysiology24205–211. 10.1016/j.pathophys.2017.05.004
16
BagheriN.Azadegan-DehkordiF.RahimianG.Rafieian-KopaeiM.ShirzadH. (2016). Role of Regulatory T-cells in different clinical expressions of Helicobacter pylori infection.Arch. Med. Res.47245–254. 10.1016/j.arcmed.2016.07.013
17
BartchewskyW.Jr.MartiniM. R.SquassoniA. C.AlvarezM. C.LadeiraM. S.SalvatoreD. M.et al (2010). Effects of Helicobacter pylori infection on the expressions of Bax and Bcl-2 in patients with chronic gastritis and gastric cancer.Dig. Dis. Sci.55111–116. 10.1007/s10620-008-0699-7
18
BélangerS.CôtéM.LaneD.L’EspéranceS.RancourtC.PichéA. (2005). Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells.Gynecol. Oncol.97796–806. 10.1016/j.ygyno.2005.02.018
19
BiegingK. T.MelloS. S.AttardiL. D. (2014). Unravelling mechanisms of p53-mediated tumour suppression. Unravelling mechanisms of p53-mediated tumour suppression.Nat. Rev. Cancer.14359–370. 10.1038/nrc3711
20
Blanco-AparicioC.CarneroA. (2013). Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.Biochem. Pharmacol.85629–643. 10.1016/j.bcp.2012.09.018
21
BögerC.BehrensH. M.RöckenC. (2016). Ki67–An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity.J. Surg. Oncol.11346–54. 10.1002/jso.24104
22
BrimH.KumarK.NazarianJ.HathoutY.JafarianA.LeeE.et al (2011). SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas.PLoS One6:e20216. 10.1371/journal.pone.0020216
23
CaggiariL.MioloG.BuonadonnaA.BasileD.SanteufemiaD. A.CossuA.et al (2017). Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype.Int. J. Mol. Sci.19:E47. 10.3390/ijms19010047
24
CavardC.TerrisB.GrimberG.ChristaL.AudardV.Radenen-BussiereB.et al (2006). Over expression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations.Oncogene25599–608. 10.1038/sj.onc.1208860
25
ChaY.KimK. J.HanS. W.RheeY. Y.BaeJ. M.WenX.et al (2016). Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.Br. J. Cancer115164–171. 10.1038/bjc.2016.176
26
ChakrabortyS.KaurS.GuhaS.BatraS. K. (2012). The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.Biochim. Biophys. Acta1826129–169. 10.1016/j.bbcan.2012.03.008
27
ChassaingB.SrinivasanG.DelgadoM. A.YoungA. N.GewirtzA. T.Vijay-KumarM. (2012). Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation.PLoS One7:e44328. 10.1371/journal.pone.0044328
28
ChenZ. F.HuangZ. M.XueH. B.LinX. Q.ChenR. P.ChenM. J.et al (2017). REG3A promotes the proliferation, migration, and invasion of gastric cancer cells.Onco Targets Ther.102017–2023. 10.2147/OTT.S131443
29
ChengH.WangX.LiT.ChenL. (2015). Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.Med. Oncol.32:389. 10.1007/s12032-014-0389-6
30
ChiurilloM. A. (2015). Role of the Wnt/β-catenin pathway in gastric cancer: an in-depth literature review.World J. Exp. Med.584–102. 10.5493/wjem.v5.i2.84
31
ChmielaM.KarwowskaZ.GonciarzW.AllushiB.Sta̧czekP. (2017). Host pathogen interactions in Helicobacter pylori related gastric cancer.World J. Gastroenterol.231521–1540. 10.3748/wjg.v23.i9.1521
32
ChoiB.SuhY.KimW. H.ChristaL.ParkJ.BaeC. D. (2007). Downregulation of regenerating islet-derived 3 alpha (REG3A) in primary human gastric adenocarcinomas.Exp. Mol. Med.39796–804. 10.1038/emm.2007.86
33
ChoiJ.KimS. G.KimB. G.KohS. J.KimJ. W.LeeK. L. (2016). Helicobacter pylori eradication modulates aberrant CpG island hypermethylation in gastric carcinogenesis.Korean J. Gastroenterol.68253–259. 10.4166/kjg.2016.68.5.253
34
Christ-CrainM.MullerB. (2008). Calcitonin peptides—the mediators in sepsis or just another fairy tale?Crit. Care Med.361684–1687. 10.1097/CCM.0b013e3181726819
35
CoppsJ.MurphyR. F.LovasS. (2009). The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.Protein Pept. Lett.161504–1518. 10.2174/092986609789839269
36
CorfieldA. P.CarrollD.MyerscoughN.ProbertC. S. (2001). Mucins in the gastrointestinal tract in health and disease.Front. Biosci.6D1321–D1357.
37
CorreaP.PiazueloM. B. (2012). The gastric precancerous cascade.J. Dig. Dis.132–9. 10.1111/j.1751-2980.2011.00550.x
38
Cortés-MárquezA. C.Mendoza-ElizaldeS.Arenas-HuerteroF.Trillo-TinocoJ.Valencia-MayoralP.Consuelo-SánchezA.et al (2018). Differential expression of miRNA-146a and miRNA-155 in gastritis induced by Helicobacter pylori infection in paediatric patients, adults, and an animal model.BMC Infect. Dis.18:463. 10.1186/s12879-018-3368-2
39
CzabotarP. E.LesseneG.StrasserA.AdamsJ. M. (2014). Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.Nat. Rev. Mol. Cell Biol.1549–63. 10.1038/nrm3722
40
CzajaM.SzarszewskiA.KamiñskaB.Bogotko-SzarszewskaM.LuczakG.KozielskaE.et al (2008). Serum gastrin concentration and changes in G and D cell densities in gastric antrum in children with chronic gastritis.Int. J. Clin. Pract.621044–1049. 10.1111/j.1742-1241.2007.01311.x
41
De AngelisG. L.CavallaroL. G.MaffiniV.MoussaA. M.FornaroliF.LiatopoulouS.et al (2007). Usefulness of a serological panel test in the assessment of gastritis in symptomatic children.Dig. Dis.25206–213. 10.1159/000103886
42
DeutschS. I.TangA. H.BurketJ. A.BensonA. D. (2014). NMDA receptors on the surface of cancer cells: target for chemotherapy?Biomed. Pharmacother.68493–496. 10.1016/j.biopha.2014.03.012
43
DingY. B.ChenG. Y.XiaJ. G.ZangX. W.YangH. Y.YangL. (2003). Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma.World J. Gastroenterol.91409–1414.
44
Domínguez-SotoA.Sierra-FilardiE.Puig-KrögerA.Pérez-MacedaB.Gómez-AguadoF.CorcueraM. T.et al (2011). Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10.J. Immunol.1862192–2200. 10.4049/jimmunol.1000475
45
EbertM. P.YuJ.HoffmannJ.RoccoA.RöckenC.KahmannS.et al (2003). Loss of beta-catenin expression in metastatic gastric cancer.J. Clin. Oncol.211708–1714. 10.1200/jco.2003.10.017
46
El HageF.StroobantV.VergnonI.BaurainJ. F.EchchakirH.LazarV.et al (2008). Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway.Proc. Natl. Acad. Sci. U.S.A.10510119–10124. 10.1073/pnas.0802753105
47
ErnstP. B.GoldB. D. (1999). Helicobacter pylori in childhood: new insights into the immunopathogenesis of gastric disease and implications for managing infection in children.J. Pediatr. Gastroenterol. Nutr.28462–473. 10.1097/00005176-199905000-00005
48
EtoS.YoshikawaK.ShimadaM.HigashijimaJ.TokunagaT.NakaoT.et al (2015). The relationship of CD133, histone deacetylase 1 and Thrombospondin-1 in gastric cancer.Anticancer Res.352071–2076.
49
FanL.ZhuQ.LiuL.ZhuC.HuangH.LuS.et al (2017). CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion.Oncotarget853244–53261. 10.18632/oncotarget.18387
50
FDA-NIH Biomarker Working Group (2019). BEST (Biomarkers, EndpointS, and other Tools) Resource.Silver Spring, MD: Food and Drug Administration.
51
FukudaY.IsomotoH.OhnitaK.OmagariK.MizutaY.MuraseK.et al (2003). Impact of CagA status on serum gastrin and pepsinogen I and II concentrations in Japanese children with Helicobacter pylori infection.J. Int. Med. Res.31247–252. 10.1177/147323000303100401
52
GanapathyV.ThangarajuM.GopalE.MartinP. M.ItagakiS.MiyauchiS.et al (2008). Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.AAPS J.10:193. 10.1208/s12248-008-9022-y
53
GaoM.LiangX. J.ZhangZ. S.MaW.ChangZ. W.ZhangM. Z. (2013). Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features.Asian Pac. J. Trop. Med.6260–264. 10.1016/S1995-7645(13)60054-1
54
GeorgakilasA. G.MartinO. A.BonnerW. M. (2017). p21: a two-faced genome guardian.Trends Mol. Med.23310–319. 10.1016/j.molmed.2017.02.001
55
GongJ.WangJ.RenK.LiuC.LiB.ShiY. (2009). Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.J. Surg. Res.15317–22. 10.1016/j.jss.2008.03.033
56
GortE. H.SuijkerbuijkK. P.RoothaanS. M.RamanV.VooijsM.van der WallE.et al (2008). Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer.Cancer Epidemiol. Biomarkers Prev.173325–3330. 10.1158/1055-9965.EPI-08-0472
57
GrossfeldG. D.GinsbergD. A.SteinJ. P.BochnerB. H.EsrigD.GroshenS.et al (1997). Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.J. Natl. Cancer Inst.89219–227. 10.1093/jnci/89.3.219
58
GrunnetM.Mau-SørensenM.BrünnerN. (2013). Tissue inhibitor of metalloproteinase 1 (TIMP-1) as a biomarker in gastric cancer: a review.Scand. J. Gastroenterol.48899–905. 10.3109/00365521.2013.812235
59
GuanZ.ZhangJ.SongS.DaiD. (2013). Promoter methylation and expression of TIMP3 gene in gastric cancer.Diagn. Pathol.8:110. 10.1186/1746-1596-8-110
60
GuarisoG.BassoD.BortoluzziC. F.MeneghelA.SchiavonS.FogarP.et al (2009). GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children.Clin. Chim. Acta40254–60. 10.1016/j.cca.2008.12.014
61
HaleyK. P.GaddyJ. A. (2015). Helicobacter pylori: genomic insight into the host-pathogen interaction.Int. J. Genomics2015:386905. 10.1155/2015/386905
62
HanadaK.GrahamD. Y. (2014). Helicobacter pylori and the molecular pathogenesis of intestinal-type gastric carcinoma.Expert Rev. Anticancer Ther.14947–954. 10.1586/14737140.2014.911092
63
HarunaH.ShimizuT.OhtsukaY.YaritaY.FujiiT.KudoT.et al (2008). Expression of COX-1, COX-2, and PPAR-gamma in the gastric mucosa of children with Helicobacter pylori infection.Pediatr. Int.501–6. 10.1111/j.1442-200X.2007.02504.x
64
Hashemi GoradelN.NajafiM.SalehiE.FarhoodB.MortezaeeK. (2019). Cyclooxygenase-2 in cancer: a review.J. Cell Physiol.2345683–5699. 10.1002/jcp.27411
65
HooiJ. K. Y.LaiW. Y.NgW. K.SuenM. M. Y.UnderwoodF. E.TanyingohD.et al (2017). Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis.Gastroenterology153420–429. 10.1053/j.gastro.2017.04.022
66
HouX.ZhangY.QiaoH. (2016). CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway.Tumour Biol.37641–651. 10.1007/s13277-015-3825-0
67
HouZ.XieL.YuL.QianX.LiuB. (2012). MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.Med. Oncol.29886–892. 10.1007/s12032-011-9862-7
68
HuangH.LiJ.HuW. J.ChenM. H.ChenS. S.ChenC.et al (2018). Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: a meta-analysis.J. BUON231185–1194.
69
HuangT.WangL.LiuD.LiP.XiongH.ZhuangL.et al (2017). FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.Int. J. Oncol.501501–1512. 10.3892/ijo.2017.3927
70
HuangY. K.YuJ. C.KangW. M.MaZ. Q.YeX.TianS. B.et al (2015). Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis.PLoS One10:e0142080. 10.1371/journal.pone.0142080
71
HyamsJ. S.Di LorenzoC.SapsM.ShulmanR. J.StaianoA.van TilburgM. (2016). Functional disorders: children and adolescents.Gastroenterology[Epub ahead of print].
72
IkuseT.OhtsukaY.KudoT.HosoiK.ObayashiN.JimboK. (2012). Microarray analysis of gastric mucosa among children with Helicobacter pylori infection.Pediatr. Int.54319–324. 10.1111/j.1442-200X.2012.03573.x
73
IzadpanahM. H.AbbaszadeganM. R.FahimY.ForghanifardM. M. (2017). Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.Cell. Mol. Biol. Lett.22:33. 10.1186/s11658-017-0065-x
74
JacksonH. W.DefamieV.WaterhouseP.KhokhaR. (2017). TIMPs: versatile extracellular regulators in cancer.Nat. Rev. Cancer1738–53. 10.1038/nrc.2016.115
75
JavanbakhtM.AkhavanmoghadamJ.TalaeiA. J.AghyaniM.MozafariM.KhedmatL.et al (2017). Differential expression of two genes Oct-4 and MUC5AC associates with poor outcome in patients with gastric cancer.Clin. Exp. Pharmacol. Physiol.441099–1105. 10.1111/1440-1681.12840
76
JiangY.ZhangC.ChenK.ChenZ.SunZ.ZhangZ.et al (2014). The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.PLoS One9:e114748. 10.1371/journal.pone.0114748
77
JonckheereN.VincentA.Franquet-AnsartH.Witte-BoumaJ.Korteland-van MaleA.LeteurtreE.et al (2012). GATA-4/-6 and HNF-1/-4 families of transcription factors control the transcriptional regulation of the murine Muc5ac mucin during stomach development and in epithelial cancer cells.Biochim. Biophys. Acta1819869–876. 10.1016/j.bbagrm.2012.04.003
78
JonesN. L.ShannonP. T.CutzE.YegerH.ShermanP. M. (1997). Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection.Am. J. Pathol.1511695–1703.
79
KainovY.FavorskayaI.DelektorskayaV.ChemerisG.KomelkovA.ZhuravskayaA.et al (2014). CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors.Cell Cycle131530–1539. 10.4161/cc.28475
80
KalisperatiP.SpanouE.PaterasI. S.KorkolopoulouP.VarvarigouA.KaravokyrosI.et al (2017). Inflammation, DNA damage, Helicobacter pylori and gastric tumorigenesis.Front. Genet.8:20. 10.3389/fgene.2017.00020
81
KangG. H.LeeS.ChoN. Y.GandamihardjaT.LongT. I.WeisenbergerD. J.et al (2008). DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis.Lab. Invest.88161–170. 10.1038/labinvest.3700707
82
KarimiP.IslamiF.AnandasabapathyS.FreedmanN.KamangarF. (2014). Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.Cancer Epidemiol. Biomarkers Prev.23700–713. 10.1158/1055-9965.EPI-13-1057
83
KassemE.NaamnaM.MawassyK.Beer-DavidsonG.MuhsenK. (2017). Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study.Eur. J. Pediatr.1761099–1105. 10.1007/s00431-017-2955-3
84
KatoS.OzawaK.KoikeT.SekineH.OharaS.MinouraT.et al (2004). Effect of Helicobacter pylori infection on gastric acid secretion and meal-stimulated serum gastrin in children.Helicobacter9100–105. 10.1111/j.1083-4389.2004.00205.x
85
KazerounianS.YeeK. O.LawlerJ. (2008). Thrombospondins in cancer.Cell. Mol. Life Sci.65700–712. 10.1007/s00018-007-7486-z
86
KeatesS.KeatesA. C.KatcharK.PeekR. M.Jr.KellyC. P. (2007). Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells.J. Infect. Dis.19695–103. 10.1086/518440
87
KessenbrockK.PlaksV.WerbZ. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment.Cell14152–67. 10.1016/j.cell.2010.03.015
88
KhaleghianM.ShakooriA.RazaviA. E.AzimiC. (2015). Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients.Asian Pac. J. Cancer Prev.167061–7069. 10.7314/apjcp.2015.16.16.7061
89
KienesbergerS.Perez-PerezG. I.OlivaresA. Z.BardhanP.SarkerS. A.HasanK. Z.et al (2018). When is Helicobacter pylori acquired in populations in developing countries? A birth-cohort study in Bangladeshi children.Gut Microbes9252–263. 10.1080/19490976.2017.1421887
90
KimB. J.KimJ. H.JangH. J.KimH. S. (2017). The role of anti-EGFR agents in the first-line treatment of advanced esophago-gastric adenocarcinoma: a meta-analysis.Oncotarget899033–99040. 10.18632/oncotarget.20958
91
KimJ.KimN.ParkJ. H.ChangH.KimJ.LeeD.et al (2013). The effect of Helicobacter pylori on epidermal growth factor receptor-induced signal transduction and the preventive effect of celecoxib in gastric cancer cells.Gut Liver7552–559. 10.5009/gnl.2013.7.5.552
92
KimK. M.OhY. L.KoJ. S.ChoeY. H.SeoJ. K. (2004). Histopathology and expression of Ki-67 and cyclooxygenase-2 in childhood Helicobacter pylori gastritis.J. Gastroenterol.39231–237. 10.1007/s00535-003-1282-9
93
KimM. S.YamashitaK.BaekJ. H.ParkH. L.CarvalhoA. L.OsadaM.et al (2006). N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.Cancer Res.663409–3418. 10.1158/0008-5472.CAN-05-1608
94
KimN.JungH. C. (2010). The role of serum pepsinogen in the detection of gastric cancer.Gut Liver4307–319. 10.5009/gnl.2010.4.3.307
95
KodamaM.FujiokaT.MurakamiK.OkimotoT.SatoR.WatanabeK.et al (2005). Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa.J. Gastroenterol. Hepatol.20941–946. 10.1111/j.1440-1746.2005.03880.x
96
KoivusaloA. I.PakarinenM. P.KolhoK. L. (2007). Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children?Diagn. Microbiol. Infect. Dis.5735–38. 10.1016/j.diagmicrobio.2006.06.022
97
KongD. H.KimY. K.KimM. R.JangJ. H.LeeS. (2018). Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer.Int. J. Mol. Sci.19:E1057. 10.3390/ijms19041057
98
LakshmananI.RachaganiS.HaukeR.KrishnS. R.PaknikarS.SeshacharyuluP.et al (2016). MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling.Oncogene354112–4121. 10.1038/onc.2015.478
99
LeungS. Y.YuenS. T.ChuK. M.MathyJ. A.LiR.ChanA. S.et al (2004). Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer.Gastroenterology127457–469. 10.1053/j.gastro.2004.05.031
100
LiC. L.NieH.WangM.SuL. P.LiJ. F.YuY. Y.et al (2012). microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis.Oncol. Rep.271960–1966. 10.3892/or.2012.1719
101
LiL.ChenX. P.LiY. J. (2010). MicroRNA-146a and human disease.Scand. J. Immunol.71227–231. 10.1111/j.1365-3083.2010.02383.x
102
LiL.GuoL.WangQ.LiuX.ZengY.WenQ.et al (2017). DAPK1 as an independent prognostic marker in liver cancer.PeerJ5:e3568. 10.7717/peerj.3568
103
LiL. T.JiangG.ChenQ.ZhengJ. N. (2015). Ki67 is a promising molecular target in the diagnosis of cancer (review).Mol. Med. Rep.111566–1572. 10.3892/mmr.2014.2914
104
LiN.XieC.LuN. H. (2016). p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?Oncotarget766276–66286. 10.18632/oncotarget.11414
105
LiX.NaH.XuL.ZhangX.FengZ.ZhouX.et al (2020). DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.Biomed. Pharmacother.121:109644. 10.1016/j.biopha.2019.109644
106
LiuJ. W.KimM. S.NagpalJ.YamashitaK.PoetaL.ChangX.et al (2007). Quantitative hypermethylation of NMDAR2B in human gastric cancer.Int. J. Cancer1211994–2000. 10.1002/ijc.22934
107
LiuR. Z.GarciaE.GlubrechtD. D.PoonH. Y.MackeyJ. R.GodboutR. (2015). CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.Mol. Cancer14:129. 10.1186/s12943-015-0380-7
108
LopesA. I.PalhaA.LopesT.MonteiroL.OleastroM.FernandesA. (2006). Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.Scand. J. Gastroenterol.41524–531. 10.1080/00365520500337098
109
LuoD.-H.ZhouQ.HuS.-K.XiaY.XuC.LinT.et al (2014). Differential expression of Notch1 intracellular domain and p21 proteins, and their clinical significance in gastric cancer.Oncol. Lett.7471–478. 10.3892/ol.2013.1751
110
MaciorkowskaE.Guziñska-UstymowiczK.RyszczukE.KemonaA.KaczmarskiM. (2009). The EGFR expression in gastric mucosa of children infected with Helicobacter pylori.Adv. Med. Sci.54187–193. 10.2478/v10039-009-0049-9
111
MaciorkowskaE.KaczmarskiM.PanasiukA.Kondej-MuszynskaK.KemonaiA. (2005). Soluble adhesion molecules ICAM-1, VCAM-1, P-selectin in children with Helicobacter pylori infection.World J. Gastroenterol.116745–6750.
112
MaciorkowskaE.PanasiukA.Kondej-MuszyñskaK.KaczmarskiM.KemonaA. (2006). Mucosal gastrin cells and serum gastrin levels in children with Helicobacter pylori infection.Adv. Med. Sci.51137–141.
113
MaedaK.NishiguchiY.KangS. M.YashiroM.OnodaN.SawadaT.et al (2001). Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer.Oncol. Rep.8763–766.
114
MartinelliC. M. D. S.LengertA. V. H.CárcanoF. M.SilvaE. C. A.BraitM.LopesL. F.et al (2016). MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients.Oncotarget850608–50617. 10.18632/oncotarget.11167
115
McMahonS. B. (2014). MYC and the control of apoptosis.Cold Spring Harb. Perspect. Med.4:a014407. 10.1101/cshperspect.a014407
116
MeloS.FigueiredoJ.FernandesM. S.GonçalvesM.Morais-de-SáE.SanchesJ. M.et al (2017). Predicting the functional impact of CDH1 missense mutations in hereditary diffuse gastric cancer.Int. J. Mol. Sci.18:E2687. 10.3390/ijms18122687
117
MiyakeT.UedaY.MatsuzakiS.MiyatakeT.YoshinoK.FujitaM.et al (2011). CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma.J. Cancer Res. Clin. Oncol.137715–722. 10.1007/s00432-010-0930-8
118
MuñozL.CamorlingaM.HernándezR.GionoS.RamónG.MuñozO.et al (2007). Immune and proliferative cellular responses to Helicobacter pylori infection in the gastric mucosa of Mexican children.Helicobacter12224–230. 10.1111/j.1523-5378.2007.00493.x
119
NakayamaY.LinY.HongoM.HidakaH.KikuchiS. (2017). Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan.Helicobacter22:e12363. 10.1111/hel.12363
120
NardoneG.StaibanoS.RoccoA.MezzaE.BalzanoT.SalvatoreG.et al (2001). Effect of Helicobacter pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy.Dig. Liver Dis.33743–749. 10.1016/s1590-8658(01)80690-3
121
NardoneG.StaibanoS.RoccoA.MezzaE.D’armientoF. P.InsabatoL.et al (1999). Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis.Gut44789–799. 10.1136/gut.44.6.789
122
NivY. (2015). Helicobacter pylori and gastric mucin expression: a systematic review and meta-analysis.World J. Gastroenterol.219430–9436. 10.3748/wjg.v21.i31.9430
123
NuñezF.BravoS.CruzatF.MontecinoM.De FerrariG. V. (2011). Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells.PLoS One6:e18562. 10.1371/journal.pone.0018562
124
ObayashiN.OhtsukaY.HosoiK.IkuseT.JimboK.AoyagiY.et al (2016). Comparison of gene expression between pediatric and adult gastric mucosa with Helicobacter pylori Infection.Helicobacter21114–123. 10.1111/hel.12245
125
OrellanaA.O’RyanM. L.LagomarcinoA. J.GeorgeS.MuñozM. S.MamaniN.et al (2016). Helicobacter pylori infection is associated with decreased expression of SLC5A8, a cancer suppressor gene, in young children.Front. Cell. Infect. Microbiol.6:121. 10.3389/fcimb.2016.00121
126
O’RyanM. L.LuceroY.RabelloM.MamaniN.SalinasA. M.PenaA.et al (2015). Persistent and transient Helicobacter pylori infections in early childhood.Clin. Infect. Dis.61211–218. 10.1093/cid/civ256
127
OzturkY.OzerE.LebeB.BekemO.BuyukgebizB. (2005). Immunohistochemical evaluation of p53 expression and proliferative activity in children with Helicobacter pylori associated gastritis.J. Pediatr. Gastroenterol. Nutr.40467–470. 10.1097/01.mpg.0000148832.22130.d7
128
PaixãoV. A.VidalD. O.CaballeroO. L.VettoreA. L.ToneL. G.RibeiroK. B.et al (2006). Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.Leuk. Res.30891–894. 10.1016/j.leukres.2005.11.016
129
ParikhA.StephanA.-F.TzanakakisE. S. (2012). Regenerating proteins and their expression, regulation and signaling.Biomol. Concepts357–70. 10.1515/bmc.2011.055
130
ParkJ. S.YeomJ. S.SeoJ. H.LimJ. Y.ParkC. H.WooH. O.et al (2015). Immunohistochemical expressions of MUC2, MUC5AC, and MUC6 in normal, Helicobacter pylori infected and metaplastic gastric mucosa of children and adolescents.Helicobacter20260–268. 10.1111/hel.12198
131
Pérez-PérezG. I.SackR. B.ReidR.SantoshamM.CrollJ.BlaserM. J. (2003). Transient and persistent Helicobacter pylori colonization in Native American children.J. Clin. Microbiol.412401–2407. 10.1128/jcm.41.6.2401-2407.2003
132
PersaudS. D.ParkS. W.Ishigami-YuasaM.Koyano-NakagawaN.KagechikaH.WeiL.-N. (2016). All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation.Sci. Rep.6:22396. 10.1038/srep22396
133
PetriniI.LencioniM.VasileE.FornaroL.BelluominiL.PasquiniG.et al (2017). EGFR and AKT1 over expression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.Cancer Biomark.21731–741. 10.3233/CBM-170865
134
PlonkaM.BielanskiW.KonturekS. J.TargoszA.SliwowskiZ.DobrzanskaM.et al (2006). Helicobacter pylori infection and serum gastrin, ghrelin and leptin in children of Polish shepherds.Dig. Liver Dis.3891–97.
135
PlummerM.de MartelC.VignatJ.FerlayJ.BrayF.FranceschiS. (2016). Global burden of cancers attributable to infections in: a synthetic analysis.Lancet Glob. Health4e609–e616. 10.1016/S2214-109X(16)30143-7
136
QuY.ZhangH.SunW.HanY.LiS.QuY.et al (2018). MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2.Cancer Sci.109618–628. 10.1111/cas.13472
137
RajaU. M.GopalG.ShirleyS.RamakrishnanA. S.RajkumarT. (2017). Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer.Cytokine8982–90. 10.1016/j.cyto.2016.08.032
138
RamachandranJ.SantoL.SiuK. T.PanaroniC.RajeN. (2016). Pim2 is important for regulating DNA damage response in multiple myeloma cells.Blood Cancer J.6:e462. 10.1038/bcj.2016.73
139
RautelinH.TervahartialaT.LauhioA.SorsaT.KolhoK. L. (2010). Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis.Scand. J. Clin. Lab. Invest.70492–496. 10.3109/00365513.2010.520732
140
RazaviA.BagheriN.Azadegan-DehkordiF.ShirzadM.RahimianG.Rafieian-KopaeiM.et al (2015). Comparative immune response in children and adults with H. pylori Infection.J. Immunol. Res.2015:315957. 10.1155/2015/315957
141
RogersL. M.BoyE.MillerJ. W.GreenR.RodriguezM.ChewF.et al (2003). Predictors of cobalamin deficiency in Guatemalan school children: diet, Helicobacter pylori, or bacterial overgrowth?J. Pediatr. Gastroenterol. Nutr.3627–36. 10.1097/00005176-200301000-00008
142
RomaE.LoutsiH.BarbatisC.PanayiotouJ.KafritsaY.RokkasT.et al (2006). Serum pepsinogen I (PGI) and gastrin levels in children with gastritis.Ann. Gastroenterol.19347–350.
143
RyszczukE.Roszko-KirpszaI.Guziñska-UstymowiczK.OlejnikB. J.KaczmarskiM. G.MaciorkowskaE. (2016). EGFR and Bcl-2 in gastric mucosa of children infected with Helicobacter pylori.Postepy Hig. Med. Dosw.70258–264. 10.5604/17322693.1198272
144
SafC.GulcanE. M.OzkanF.Cobanoglu SafS. P.VitrinelA. (2015). Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis.Eur. J. Gastroenterol. Hepatol.27155–161. 10.1097/MEG.0000000000000246
145
SaghebH.HeidariZ.JahantighM.NaroueiM. (2016). Immunohistochemical expression of p53 and Ki-67 genes in gastric cancer and precancerous lesions in the patients with Helicobacter pylori infection.Gene Cell Tissue3:e41341. 10.17795/gct-41341
146
SakamotoA.AkiyamaY.ShimadaS.ZhuW. G.YuasaY.TanakaS. (2015). DNA methylation in the Exon 1 region and complex regulation of Twist1 expression in gastric cancer cells.PLoS One10:e0145630. 10.1371/journal.pone.0145630
147
SamloffI. M. (1971). Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence.Gastroenterology61185–188. 10.1016/s0016-5085(19)33596-6
148
SamloffI. M.LiebmanW. M. (1973). Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence.Gastroenterology6536–42. 10.1016/s0016-5085(19)33138-5
149
SatoH.IshiharaS.KawashimaK.MoriyamaN.SuetsuguH.KazumoriH.et al (2000). Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists.Br. J. Cancer831394–1400. 10.1054/bjoc.2000.1457
150
SchutyserE.RichmondA.Van DammeJ. (2005). Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.J. Leukoc. Biol.7814–26. 10.1189/jlb.1204712
151
ShimazuT.AsadaK.CharvatH.KusanoC.OtakeY.KakugawaY.et al (2015). Association of gastric cancer risk factors with DNA methylation levels in gastric mucosa of healthy Japanese: a cross-sectional study.Carcinogenesis361291–1298. 10.1093/carcin/bgv125
152
ShinS. H.ParkS. Y.KoJ. S.KimN.KangG. H. (2011). Aberrant CpG island hypermethylation in pediatric gastric mucosa in association with Helicobacter pylori infection.Arch. Pathol. Lab. Med.135759–765. 10.1043/2010-0140-OA.1
153
ShiotaS.YamaokaY. (2014). Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.Biomark. Med.81127–1137. 10.2217/bmm.14.72
154
ShomaliN.MansooriB.MohammadiA.ShirafkanN.GhasabiM.BaradaranB. (2017). MiR-146a functions as a small silent player in gastric cancer.Biomed. Pharmacother.96238–245. 10.1016/j.biopha.2017.09.138
155
SierraJ. C.AsimM.VerriereT. G.PiazueloM. B.SuarezG.Romero-GalloJ.et al (2017). Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.Gut671247–1260. 10.1136/gutjnl-2016-312888
156
SkieruchaM.MilneA. N.OfferhausG. J.PolkowskiW. P.MaciejewskiR.SitarzR. (2016). Molecular alterations in gastric cancer with special reference to the early-onset subtype.World J. Gastroenterol.222460–2474. 10.3748/wjg.v22.i8.2460
157
SmithJ. P.NadellaS.OsborneN. (2017). Gastrin and gastric cancer.Cell. Mol. Gastroenterol. Hepatol.475–83. 10.1016/j.jcmgh.2017.03.004
158
SongX.XinN.WangW.ZhaoC. (2015). Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis.Oncotarget635579–35588. 10.18632/oncotarget.5758
159
TamuraH.SuzukiM.MoriyaY.HoshinoH.OkamotoT.YoshidaS.et al (2011). Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.BMC Cancer11:220. 10.1186/1471-2407-11-220
160
TanakaK.ImotoI.InoueJ.KozakiK.TsudaH.ShimadaY.et al (2007). Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.Oncogene266456–6468. 10.1038/sj.onc.1210459
161
TehM.TanK. B.SeetB. L.YeohK. G. (2002). Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis.Cancer95499–505. 10.1002/cncr.10697
162
TokunagaR.ZhangW.NaseemM.PucciniA.BergerM. D.SoniS.et al (2018). CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.Cancer Treat. Rev.6340–47. 10.1016/j.ctrv.2017.11.007
163
TriantafyllouK.PapadopoulosV.EmanouilT.GkolfakisP.DamaskouV.TziatziosG.et al (2016). Eradication of Helicobacter pylori infection restores ki67, p53, and Cyclin D1 immunoreactivity in the human gastric epithelium.Clin. Med. Insights Gastroenterol.973–78. 10.4137/CGast.S38330
164
UenoM.ToyotaM.AkinoK.SuzukiH.KusanoM.SatohA.et al (2004). Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.Tumour Biol.25134–140. 10.1159/000079145
165
ValenzuelaM. A.CanalesJ.CorvalánA. H.QuestA. F. (2015). Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.World J. Gastroenterol.2112742–12756. 10.3748/wjg.v21.i45.12742
166
van der PostR. S.CarneiroF. (2017). Emerging concepts in gastric neoplasia: heritable gastric cancers and polyposis disorders.Surg. Pathol. Clin.10931–945. 10.1016/j.path.2017.07.011
167
VaneJ. R.BakhleY. S.BottingR. M. (1998). Cyclooxygenases 1 and 2.Annu. Rev. Pharmacol. Toxicol.3897–120. 10.1146/annurev.pharmtox.38.1.97
168
VelikovaG.BanksR. E.GearingA.HemingwayI.ForbesM. A.PrestonS. R.et al (1997). Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer.Br. J. Cancer761398–1404. 10.1038/bjc.1997.569
169
VellaV.NicolosiM. L.GiulianoS.BellomoM.BelfioreA.MalaguarneraR. (2017). PPAR-γ agonists as antineoplastic agents in cancers with dysregulated IGF axis.Front. Endocrinol.8:31. 10.3389/fendo.2017.00031
170
Villarreal-CalderonR.Luevano-GonzalezA.Aragon-FloresM.ZhuH.YuanY.XiangQ.et al (2014). Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.Ann. Diagn. Pathol.18129–135. 10.1016/j.anndiagpath.2014.02.003
171
WaldumH. L.SagatunL.MjønesP. (2017). Gastrin and gastric cancer.Front. Endocrinol.8:1. 10.3389/fendo.2017.00001
172
WangH. J.HeX. J.MaY. Y.JiangX. T.XiaY. J.YeZ. Y.et al (2010). Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.Anat. Rec.2931855–1863. 10.1002/ar.21230
173
WeeP.WangZ. (2017). Epidermal growth factor receptor cell proliferation signaling pathways.Cancers9:E52. 10.3390/cancers9050052
174
WeiY.LinC.LiH.XuZ.WangJ.LiR.et al (2018). CXCL13 expression is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer.Cancer Immunol. Immunother.67261–269. 10.1007/s00262-017-2083-y
175
WenX. Z.AkiyamaY.PanK. F.LiuZ. J.LuZ. M.ZhouJ.et al (2010). Methylation of GATA-4 and GATA-5 and development of sporadic gastric carcinomas.World J. Gastroenterol.161201–1208. 10.3748/wjg.v16.i10.1201
176
WuJ.LinK.ZengJ.LiuW.YangF.WangX.et al (2014). Role of DC-SIGN in Helicobacter pylori infection of gastrointestinal cells.Front. Biosci.19825–834. 10.2741/4250
177
XiaG.Schneider-StockR.DiestelA.HaboldC.KruegerS.RoessnerA.et al (2008). Helicobacter pylori regulates p21WAF1 by histone H4 acetylation.Biochem. Biophys. Res. Commun.369526–531. 10.1016/j.bbrc.2008.02.073
178
XieX. Z.ZhaoZ. G.QiD. S.WangZ. M. (2006). Assay of gastrin and somatostatin in gastric antrum tissues of children with chronic gastritis and duodenal ulcer.World J. Gastroenterol.122288–2290. 10.3748/wjg.v12.i14.2288
179
XinH.DengY.CaoJ. (2018). Proviral insertion in murine lymphomas 2 promotes stomach cancer progression by regulating apoptosis via reactive oxygen species-triggered endoplasmic reticulum stress.Biochem. Biophys. Res. Commun.506145–152. 10.1016/j.bbrc.2018.09.062
180
YamazoeS.TanakaH.SawadaT.AmanoR.YamadaN.OhiraM.et al (2010). RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.J. Exp. Clin. Cancer Res.29:53. 10.1186/1756-9966-29-53
181
YangZ.ZhangX.GangH.LiX.LiZ.WangT.et al (2007). Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression.Biochem. Biophys. Res. Commun.358925–930. 10.1016/j.bbrc.2007.05.023
182
YaoD.ShiJ.ShiB.WangN.LiuW.ZhangG.et al (2012). Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer.Clin. Chim. Acta413787–794. 10.1016/j.cca.2012.01.013
183
YaoL.LiuF.SunL.WuH.GuoC.LiangS.et al (2010). Upregulation of PPARgamma in tissue with gastric carcinoma.Hybridoma29341–343. 10.1089/hyb.2010.0013
184
YeY.XiaoL.WangS. J.YueW.YinQ. S.SunM. Y.et al (2016). Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.Oncotarget73921–3933. 10.18632/oncotarget.6473
185
YildirimM.KayaV.DemirpenceO.GunduzS.BozcukH. (2015). Prognostic significance of p53 in gastric cancer: a meta- analysis.Asian Pac. J. Cancer Prev.16327–332. 10.7314/apjcp.2015.16.1.327
186
YoshinoN.IshiharaS.RumiM. A.Ortega-CavaC. F.YukiT.KazumoriH.et al (2005). Interleukin-8 regulates expression of Reg protein in Helicobacter pylori-infected gastric mucosa.Am. J. Gastroenterol.1002157–2166. 10.1111/j.1572-0241.2005.41915.x
187
YoungG. O.BrownS.StemmetN.LastovicaA. J.MarksI. N.ModlinI. M.et al (2002). The pepsinogen releasing effect of Helicobacter pylori lipopolysaccharide.Helicobacter730–38. 10.1046/j.1523-5378.2002.00053.x
188
YuH.XinY. (2013). Down-regulated expressions of PPARγ and its coactivator PGC-1 are related to gastric carcinogenesis and Lauren’s classification in gastric carcinoma.Chin. J. Cancer Res.25704–714. 10.3978/j.issn.1000-9604.2013.11.11
189
Zabala TorrresB.LuceroY.LagomarcinoA. J.Orellana-ManzanoA.GeorgeS.TorresJ. P.et al (2017). Review: prevalence and dynamics of Helicobacter pylori infection during childhood.Helicobacter22:e12399. 10.1111/hel.12399
190
ZazulaM.FerreiraA. M.CzopekJ. P.KolodziejczykP.Sinczak-KutaA.KlimkowskaA.et al (2006). CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion.Diagn. Mol. Pathol.1524–29. 10.1097/00019606-200603000-00004
191
ZhangC.LiZ.XuL.CheX.WenT.FanY.et al (2018). CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.BMC Cancer18:462. 10.1186/s12885-018-4384-8
192
ZhangH.FangD.-C.WangR.-Q.YangS.-M.LiuH.-F.LuoY.-H. (2004). Effect of Helicobacter pylori infection on expressions of Bcl-2 family members in gastric adenocarcinoma.World J. Gastroenterol.10227–230.
193
ZhangL.HouY.AshktorabH.GaoL.XuY.WuK.et al (2010). The impact of C-MYC gene expression on gastric cancer cell.Mol. Cell. Biochem.344125–135. 10.1007/s11010-010-0536-0
194
ZhangX. H.YuH. L.WangF. J.HanY. L.YangW. L. (2015). Pim-2 modulates aerobic glycolysis and energy production during the development of colorectal tumors.Int. J. Med. Sci.12487–493. 10.7150/ijms.10982
195
ZhengR.BlobelG. A. (2010). GATA transcription factors and cancer.Genes Cancer11178–1188. 10.1177/1947601911404223
196
ZhengY.WangL.ZhangJ. P.YangJ. Y.ZhaoZ. M.ZhangX. Y. (2010). Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma.World J. Gastroenterol.16339–344.
197
ZhouF.XuY.ShiJ.LanX.ZouX.WangL.et al (2016). Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers.Cancer Med.53403–3411. 10.1002/cam4.931
198
ZhouY.LiY.ZhengJ.LiuK.ZhangH. (2015). Detecting of gastric cancer by Bcl-2 and Ki67.Int. J. Clin. Exp. Pathol.87287– 7290.
Summary
Keywords
Helicobacter pylori, children, gastric damage, cancer biomarker, oncogene, gastric cancer biomarker
Citation
George S, Lucero Y, Torres JP, Lagomarcino AJ and O’Ryan M (2020) Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front. Microbiol. 11:90. doi: 10.3389/fmicb.2020.00090
Received
10 October 2019
Accepted
15 January 2020
Published
12 February 2020
Volume
11 - 2020
Edited by
Alain Pierre Gobert, Vanderbilt University Medical Center, United States
Reviewed by
Diane Bimczok, Montana State University, United States; Khitam Muhsen, Tel Aviv University, Israel
Updates
Copyright
© 2020 George, Lucero, Torres, Lagomarcino and O’Ryan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Miguel O’Ryan, moryan@med.uchile.cl
This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.